These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9705561)
1. Evaluation of the new automated enzymun-test anti-HBc plus for the detection of hepatitis B virus core antibody. Weber B; Michl U; Mühlbacher A; Paggi G; Bossi V Intervirology; 1998; 41(1):17-23. PubMed ID: 9705561 [TBL] [Abstract][Full Text] [Related]
2. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Berger A; Doerr HW; Rabenau HF; Weber B Intervirology; 2000; 43(2):71-6. PubMed ID: 10971123 [TBL] [Abstract][Full Text] [Related]
3. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L; Strong DM; Tegtmeier G; Stramer S Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [TBL] [Abstract][Full Text] [Related]
4. Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay. Spronk AM; Schmidt L; Krenc C; Pavlis-Jenkins L; Brady J; Taskar S; Angus-Finn L; Mimms L J Clin Microbiol; 1991 Mar; 29(3):611-6. PubMed ID: 2037680 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of Anti-HBc screening assays--which assay is best for blood donor screening? Hourfar MK; Walch LA; Geusendam G; Dengler T; Janetzko K; Gubbe K; Frank K; Karl A; Löhr M; Sireis W; Seifried E; Schmidt M Int J Lab Hematol; 2009 Dec; 31(6):649-56. PubMed ID: 18673399 [TBL] [Abstract][Full Text] [Related]
6. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics. Dati F; Denoyel G; van Helden J J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761 [TBL] [Abstract][Full Text] [Related]
7. The reliability of HBV core antibody in serological screening for hepatitis B virus. Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045 [TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive sera. Ollier L; Laffont C; Kechkekian A; Doglio A; Giordanengo V J Virol Methods; 2008 Dec; 154(1-2):206-9. PubMed ID: 18848582 [TBL] [Abstract][Full Text] [Related]
9. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera. Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838 [TBL] [Abstract][Full Text] [Related]
10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
11. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
12. A single-center, single-blind study to evaluate the clinical sensitivity, specificity, and agreement between Elecsys Anti-HBc II and Elecsys Anti-HBc in a Korean population. Lee T; Yang JJ; Eom J; Kwon S; Park BG; Hwang SH; Oh HB J Clin Virol; 2018 Dec; 109():41-44. PubMed ID: 30419551 [TBL] [Abstract][Full Text] [Related]
13. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836 [TBL] [Abstract][Full Text] [Related]
14. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen. Kantelhardt VC; Schwarz A; Wend U; Schüttler CG; Willems WR; Trimoulet P; Fleury H; Gerlich WH; Kann M J Clin Virol; 2009 Oct; 46(2):124-8. PubMed ID: 19631583 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Seo DH; Whang DH; Song EY; Kim HS; Park Q Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731 [TBL] [Abstract][Full Text] [Related]
16. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay. O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210 [TBL] [Abstract][Full Text] [Related]
17. The novel use of a routine quantitative system to analyze the activity, content and affinity of an antibody to hepatitis B core antigen. Han Y; Wang B; Liu H J Clin Virol; 2011 Dec; 52(4):295-9. PubMed ID: 21978612 [TBL] [Abstract][Full Text] [Related]
18. The diagnosis of acute viral hepatitis A or B by microparticle enzyme immunoassay. Chernesky MA; Crawford J; Castriciano S; Mahony JB J Virol Methods; 1991 Oct; 34(3):291-6. PubMed ID: 1744219 [TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays. Eble K; Clemens J; Krenc C; Rynning M; Stojak J; Stuckmann J; Hutten P; Nelson L; DuCharme L; Hojvat S J Med Virol; 1991 Mar; 33(3):139-50. PubMed ID: 1880494 [TBL] [Abstract][Full Text] [Related]
20. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]